|1|17I^-estradiol promotes the invasion and migration of nuclear estrogen receptor-negative breast cancer cells through cross-talk between GPER1 and CXCR1. (23907016)
Jiang Q.F.... Liu Z.M.
|2|Antineoplastic effects of I+-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis. (23451128)
Santha S.... Dwivedi C.
|3|High expression of class III I^-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer. (23218766)
Wang Y.... McDaid H.M.
|4|Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer. (24077732)
Covington K.R.... Fuqua S.A.
|5|The financial burden of using Oncotype Dx for patients with lymph node-negative and estrogen receptor-positive breast cancer in Australia. (23718901)
Sakata S.... Cronk M.
|6|CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. (22524805)
Ramezani F.... Maleki D.
|7|A new susceptibility locus for estrogen receptor-negative breast cancer. (22228736)
|8|Dithiolethiones inhibit NF-I_B activity via covalent modification in human estrogen receptor-negative breast cancer. (22436383)
Switzer C.H.... Wink D.A.
|9|The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women. (22362381)
Prabhu J.S.... Sridhar T.S.
|10|Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer. (22577344)
Naderi A.... Dowhan D.H.
|11|Promoter hypermethylation of estrogen receptor alpha gene is correlated to estrogen receptor negativity in Iranian patients with sporadic breast cancer. (23508069)
Izadi P.... Akbari M.T.
|12|Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer. (21457548)
Naderi A.... Liu J.
|13|Value of post-operative reassessment of estrogen receptor I+ expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer. (21516302)
Bernsdorf M.... Ejlertsen B.
|14|Study of Estrogen Receptor and Progesterone Receptor Expression in Breast Ductal Carcinoma In Situ by Immunohistochemical Staining in ER/PgR-Negative Invasive Breast Cancer. (22091428)
Dobrescu A.... Hindenburg A.A.
|15|Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. (21846820)
Palmer J.R.... Rosenberg L.
|16|Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors. (22010013)
Tang G.... Wolmark N.
|17|Targeting androgen receptor in estrogen receptor-negative breast cancer. (21741601)
Ni M.... Brown M.
|18|A feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer. (21403841)
Chia K.M.... Naderi A.
|19|Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. (22151962)
West N.R.... Watson P.H.
|20|Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. (20650001)
Rashid-Kolvear F.... Done S.J.
|21|A genome-wide association scan on estrogen receptor-negative breast cancer. (21062454)
Li J.... Hall P.
|22|Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid. (20027631)
Chu R.... Fong S.
|23|Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. (20308648)
Azzato E.M.... Pharoah P.D.
|24|Selective association of peroxiredoxin 1 with genomic DNA and COX-2 upstream promoter elements in estrogen receptor negative breast cancer cells. (20631257)
Wang X.... Davie J.R.
|25|Retraction for Ford et al., Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells. (21127265)
Ford C.E.... Anderson T.
|26|A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer. (19762336)
Kulkarni D.A.... Hirshfield K.M.
|27|Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression. (19385968)
Morimoto K.... Noguchi S.
|28|Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients. (19740422)
Yan Y.... Leygue E.
|29|A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study. (18771580)
Novelli F.... Mottolese M.
|30|Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer. (18974123)
Stein R.A.... McDonnell D.P.
|31|Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi. (18183590)
Zheng X.... Shalloway D.
|32|Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target. (18243688)
Skliris G.P.... Murphy L.C.
|33|17HSD 2 may be higher in African-American breast cancer and is associated with estrogen receptor-negative tumors. (17993718)
Yaeger R.... Joe A.K.
|34|An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. (17683518)
Teschendorff A.E.... Caldas C.
|35|Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. (17621625)
Yao C.... Wang S.M.
|36|Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor. (16505096)
Ostapkowicz A.... Spychala J.
|37|The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor-positive and estrogen receptor-negative human breast cancers. (16546983)
Chung H.... Kong G.
|38|Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. (16145046)
Arpino G.... Elledge R.M.
|39|Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression. (16012712)
Umemura S.... Osamura R.Y.
|40|Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. (16144913)
Bonofiglio D.... AndA^ S.
|41|Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. (15041725)
Mehrotra J.... Sukumar S.
|42|Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1. (12851686)
Liang Y.... Schoenlein P.V.
|43|A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. (14620913)
Keen J.C.... Davidson N.E.
|44|Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. (10900013)
Biswas D.K.... Pardee A.B.
|45|Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation. (10379895)
Lazennec G.... Katzenellenbogen B.S.
|46|A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes. (10486611)
Orr R.K.... Kuntz K.M.
|47|Differential expression of the MT-1E gene in estrogen-receptor-positive and -negative human breast cancer cell lines. (9422519)
Friedline J.A.... Sens D.A.
|48|Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. (9390536)
Fisher B.... Margolese R.G.
|49|Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. (8662863)
Gundimeda U.... Gopalakrishna R.
|50|Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines. (2379149)
Koga M.... Sutherland R.L.